SfE Survey-COVID 19 or VITT related Adrenal Haemorrhage

The purpose of this survey is to gain information about the frequency of adrenal haemorrhage and/or adrenal insufficiency in both patients with COVID-19 infection or those with definite or probable VITT.
Following this survey, we aim to collect clinical data for a UK multicentre retrospective audit.

Question Title

* 1. Your position?

Consultant Endocrinologist

Clinical Trainee in Endocrinology

Other (please specify)

Question Title

* 2. What is your type of practice?

Tertiary Hospital

District General Hospital

Private practice

Other (please specify)

Question Title

* 3. Between January 2020 to October 2021 have you been involved in the management of any patients with Adrenal Haemorrhage occurring post-COVID-19 infection?

Yes (1 case)

Yes (>1 case)

Question Title

* 4. If you chose "Yes (>1 case)" in Question 3, please state how many below

Question Title

* 5. Between January 2021 to October 2021 have you been involved as Endocrinologist in the management of patients with Adrenal Haemorrhage within presumed or defined COVID-19 Oxford-AZ Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT)

Yes (1 case)

Yes (> 1 case)

Question Title

* 6. If you chose "Yes (>1 case)" in Question 5 , please state how many below

Question Title

* 7. If You chose "No" as the response in Question 3 and 5, please stop the survey

Question Title

* 8. If you answered "yes" to question 3, was the post-COVID19 Adrenal Haemorrhage unilateral or bilateral?

Unilateral in all cases

Unilateral in some cases and bilateral in others

Bilateral in all cases

Question Title

* 9. If you chose the middle option in Question 8, please state below, how many cases were unilateral and how many bilateral

Question Title

* 10. If you answered "yes" to question 3, was the post-COVID19 Adrenal Haemorrhage associated with Adrenal Insufficiency?

Yes, in all cases

Yes, in some cases

Question Title

* 11. If you chose the middle option in Question 10, please state how many cases had adrenal insufficiency?

Question Title

* 12. If you answered "yes" to question 5, was the VITT-related Adrenal Haemorrhage associated with Adrenal Insufficiency?

Yes, in all cases

Yes, in some cases

Question Title

* 13. If you chose the middle option in Question 12, please state how many cases had adrenal insufficiency?

Question Title

* 14. Would you be happy to be contacted about your case(s) to answer more detailed questions and contribute to a publication?

Yes

Question Title

* 15. If you answered "yes" to Question 14, please provide your name and contact details.

Full Name

Hospital

Trust

Email Address

SfE Survey-COVID 19 or VITT related Adrenal Haemorrhage

Question Title

* 1. Your position?

Question Title

* 2. What is your type of practice?

Question Title

* 3. Between January 2020 to October 2021 have you been involved in the management of any patients with Adrenal Haemorrhage occurring post-COVID-19 infection?﻿

Question Title

* 4. If you chose "Yes (>1 case)" in Question 3, please state how many below

Question Title

* 5. Between January 2021 to October 2021 have you been involved as Endocrinologist in the management of patients with Adrenal Haemorrhage within presumed or defined COVID-19 Oxford-AZ Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT)

Question Title

* 6. If you chose "Yes (>1 case)" in Question 5 , please state how many below

Question Title

* 7. If You chose "No" as the response in Question 3 and 5, please stop the survey

Question Title

* 8. If you answered "yes" to question 3, was the post-COVID19 Adrenal Haemorrhage unilateral or bilateral?

Question Title

* 9. If you chose the middle option in Question 8, please state below, how many cases were unilateral and how many bilateral

Question Title

* 10. If you answered "yes" to question 3, was the post-COVID19 Adrenal Haemorrhage associated with Adrenal Insufficiency?

Question Title

* 11. If you chose the middle option in Question 10, please state how many cases had adrenal insufficiency?

Question Title

* 12. If you answered "yes" to question 5, was the VITT-related Adrenal Haemorrhage associated with Adrenal Insufficiency?

Question Title

* 13. If you chose the middle option in Question 12, please state how many cases had adrenal insufficiency?

Question Title

* 14. Would you be happy to be contacted about your case(s) to answer more detailed questions and contribute to a publication?

Question Title

* 15. If you answered "yes" to Question 14, please provide your name and contact details.

* 3. Between January 2020 to October 2021 have you been involved in the management of any patients with Adrenal Haemorrhage occurring post-COVID-19 infection?